Skip to main content
SpringerLink
Log in

Nivolumab

Diarrhoea: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Liao B, et al. Efficacy and safety of nivolumab therapy for advanced NSCLC in the expanded access named patient program in Taiwan. Journal of Thoracic Oncology 12 (Suppl. 2): S2425-S2426 abstr. P2.07-027, No. 11, Nov 2017. Available from: URL: https://doi.org/10.1016/j.jtho.2017.11.086 [abstract] -Taiwan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nivolumab. Reactions Weekly 1694, 320 (2018). https://doi.org/10.1007/s40278-018-43721-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43721-4

Search

Navigation